polymyxin b nonapeptide has been researched along with Health Care Associated Infection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramite, JA; Ackley, DC; Aubrecht, J; Brown, MF; Butler, A; Chen, JM; Crandon, JL; Dib-Hajj, F; Flanagan, ME; Granskog, K; Hardink, JR; Huband, MD; Irvine, R; Kuhn, M; Leach, KL; Li, B; Lin, J; Luke, DR; MacVane, SH; Magee, TV; McCurdy, S; McKim, JM; Miller, AA; Nguyen, TT; Nicolau, DP; Noe, MC; O'Donnell, JP; Seibel, SB; Shen, Y; Starr, JT; Stepan, AF; Tomaras, AP; Wilga, PC; Xu, J; Zhang, L | 1 |
1 other study(ies) available for polymyxin b nonapeptide and Health Care Associated Infection
| Article | Year |
|---|---|
Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections.
Topics: Animals; Anti-Bacterial Agents; beta-Alanine; Cross Infection; Dogs; Drug Discovery; Drug Resistance, Multiple; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Polymyxins; Rats | 2013 |